Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab Plus Cetuximab vs Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
NCT03944941Phase 2Active, not recruiting
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2019
- Primary completion
- Feb 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in cutaneous squamous cell carcinoma (cSCC), sponsored by Cancer and Leukemia Group B. Started Jun 2019; status: active, not recruiting.
02
Drugs
KL-140
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT03944941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944941.